Validation of a commercially available SARS-CoV-2 serological immunoassay

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Validation of a commercially available SARS-CoV-2 serological immunoassay
Authors
Keywords
COVID-19, ELISA, Pseudovirus neutralisation assay, Recombinant immunofluorescence assay, SARS-CoV-2, Serological assays, Serological testing strategy
Journal
CLINICAL MICROBIOLOGY AND INFECTION
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-06-27
DOI
10.1016/j.cmi.2020.06.024

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.